Comparability for Biologics December 4, 2007
Portland House, Stag Place
London, England
London, England
Process changes made during the manufacture of recombinant proteins can have profound implications on the quality, safety, efficacy and regulatory approval of your product.
Official Website: http://www.iir-events.com/IIR-conf/PTI/EventView.aspx?EventID=1316
Added by mBLAST on October 23, 2007